Biotech
CAMBRIDGE, MASSACHUSETTS: CAMBRIDGE, MASSACHUSETTS -- (Marketwired) -- 02/07/17 -- VBI Vaccines Inc. (NASDAQ: VBIV) (TSX: VBV) ("VBI") announced today the receipt of positive Scientific Advice from the Committee fo ...
LEXINGTON, MA: LEXINGTON, MA -- (Marketwired) -- 02/07/17 -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehyde ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 02/07/17 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TRIL) a clinical stage immuno-oncology company developing innovative therapies for the treatment of can ...
LEXINGTON, MA: LEXINGTON, MA -- (Marketwired) -- 02/06/17 -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehyde ...
HALIFAX, NOVA SCOTIA: University Health Network (UHN) in Toronto to Launch Triple-Combination Study Evaluating the Potential for Enhanced Anti-Cancer Activity of Currently Marketed Checkpoint Inhibitor When Combined With D ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 02/03/17 -- Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX: IMV)(OTCQX: IMMVF), a clinical stage vaccine and immunotherapy com ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 02/02/17 -- Immunovaccine Inc. (TSX: IMV) (OTCQX: IMMVF), a clinical stage vaccine and immunotherapy company, today announced that it will participate in this ...
TORONTO, ONTARIO: - Advancing the two ongoing clinical trials with TTI-621, an IgG1 SIRPaFc fusion protein targeting CD47; updated data anticipated in 2H/2017 - Expanding the CD47 franchise with TTI-622, an IgG4 SIRPaF ...
MIAMI, FL: $1.8M Gross Income and $1.0M Net Profit Year to Date. ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwired) -- 01/31/17 -- Invivoscribe® Technologies Inc., a global company with more than 20 years of experience providing clonality and biomarker test solutions for the fields ...
PHILADELPHIA, PA: PHILADELPHIA, PA -- (Marketwired) -- 01/31/17 -- (NASDAQ: GNMX) (the Company) announced today that the first patient has been dosed in a Phase 1/2 clinical trial to assess the efficacy of its lead i ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 01/31/17 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TR), a clinical-stage immuno-oncology company developing innovative therapies for the treatment of canc ...
SCOTTSDALE, ARIZONA: New core product sales increase 147% fourth quarter over fourth quarter ...
MENLO PARK, CA: MENLO PARK, CA -- (Marketwired) -- 01/30/17 -- Corcept Therapeutics Incorporated (NASDAQ: CORT)Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, dev ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/30/17 -- This document corrects and replaces the press release that was sent today at 8:00 am ET. The embedded URL was changed.Calyx Bio-Ventures In ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/30/17 -- Calyx Bio-Ventures Inc. (TSX VENTURE: CYX) ("Calyx" or the "Company") is pleased to provide an update on its ongoing b ...
NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 01/27/17 -- iBio, Inc. (NYSE MKT: IBIO) On January 20, 2017, the Supreme Court for the State of New York, County of New York, scheduled a hearing to consider approval ...
BASEL, SWITZERLAND: BASEL, SWITZERLAND -- (Marketwired) -- 01/26/17 -- Cellestia Biotech AG -Basel, Switzerland - January 26, 2017 - Cellestia Biotech AG, a private biopharmaceutical company with strategic focus on anti ...
GUILDFORD, UNITED KINGDOM: GUILDFORD, UNITED KINGDOM -- (Marketwired) -- 01/26/17 -- Angle PLC (AIM: AGL) (OTCQX: ANPCY)AIM:AGL OTCQX:ANPCYPatient enrolment European study now over 90% complete and US study 70% complete; Headl ...
